
PMC:7307149 / 759-2240
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T9 | 37-69 | Body_part | denotes | major histocompatibility complex | http://purl.org/sig/ont/fma/fma84079 |
T10 | 71-74 | Body_part | denotes | MHC | http://purl.org/sig/ont/fma/fma84079 |
T11 | 97-106 | Body_part | denotes | leukocyte | http://purl.org/sig/ont/fma/fma62852 |
T12 | 118-121 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T13 | 401-404 | Body_part | denotes | MHC | http://purl.org/sig/ont/fma/fma84079 |
T14 | 441-444 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T15 | 713-716 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T16 | 749-752 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T17 | 1131-1134 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T18 | 1321-1325 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T19 | 1387-1390 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T8 | 211-258 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T9 | 211-244 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T10 | 260-268 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 299-323 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 325-333 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T13 | 477-485 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T14 | 630-638 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T15 | 807-815 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T16 | 898-906 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T17 | 948-952 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T18 | 1200-1208 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 84-89 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | genes |
T9 | 91-96 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T10 | 115-116 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T11 | 122-123 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T12 | 127-128 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T13 | 137-142 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | genes |
T14 | 277-282 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T15 | 349-350 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T16 | 393-400 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
T17 | 445-446 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T18 | 449-450 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T19 | 488-496 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
T20 | 605-610 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T21 | 698-699 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T22 | 753-754 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T23 | 794-802 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
T24 | 962-966 | http://purl.obolibrary.org/obo/CLO_0004265 | denotes | H.-T |
T25 | 978-979 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T26 | 1135-1136 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T27 | 1211-1219 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
T28 | 1249-1254 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T29 | 1319-1325 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T-cell |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 107-114 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
T2 | 393-400 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
T3 | 488-496 | Chemical | denotes | peptides | http://purl.obolibrary.org/obo/CHEBI_16670 |
T4 | 794-802 | Chemical | denotes | peptides | http://purl.obolibrary.org/obo/CHEBI_16670 |
T5 | 957-960 | Chemical | denotes | Lin | http://purl.obolibrary.org/obo/CHEBI_32386 |
T6 | 1009-1012 | Chemical | denotes | BMC | http://purl.obolibrary.org/obo/CHEBI_3392 |
T7 | 1211-1219 | Chemical | denotes | peptides | http://purl.obolibrary.org/obo/CHEBI_16670 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
33 | 118-136 | Gene | denotes | HLA-A], -B, and -C | Gene:3105 |
34 | 749-754 | Gene | denotes | HLA-B | Gene:3106 |
35 | 1131-1136 | Gene | denotes | HLA-B | Gene:3106 |
36 | 954-955 | Gene | denotes | M | Gene:43740571 |
37 | 211-258 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
38 | 260-270 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
39 | 477-487 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
40 | 605-610 | Species | denotes | human | Tax:9606 |
41 | 611-624 | Species | denotes | coronaviruses | Tax:11118 |
42 | 630-640 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
43 | 807-817 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
44 | 1200-1210 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
45 | 1249-1254 | Species | denotes | human | Tax:9606 |
46 | 1255-1268 | Species | denotes | coronaviruses | Tax:11118 |
47 | 91-96 | Species | denotes | human | Tax:9606 |
48 | 441-458 | Gene | denotes | HLA-A, -B, and -C | Gene:3106 |
49 | 299-323 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
50 | 325-333 | Disease | denotes | COVID-19 | MESH:C000657245 |
51 | 898-906 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 37-69 | http://purl.obolibrary.org/obo/GO_0046776 | denotes | major histocompatibility complex |
T3 | 71-74 | http://purl.obolibrary.org/obo/GO_0046776 | denotes | MHC |
T4 | 401-404 | http://purl.obolibrary.org/obo/GO_0046776 | denotes | MHC |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 0-335 | Sentence | denotes | Genetic variability across the three major histocompatibility complex (MHC) class I genes (human leukocyte antigen A [HLA-A], -B, and -C genes) may affect susceptibility to and severity of the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). |
T12 | 336-497 | Sentence | denotes | We performed a comprehensive in silico analysis of viral peptide-MHC class I binding affinity across 145 HLA-A, -B, and -C genotypes for all SARS-CoV-2 peptides. |
T13 | 498-625 | Sentence | denotes | We further explored the potential for cross-protective immunity conferred by prior exposure to four common human coronaviruses. |
T14 | 626-725 | Sentence | denotes | The SARS-CoV-2 proteome was successfully sampled and was represented by a diversity of HLA alleles. |
T15 | 726-956 | Sentence | denotes | However, we found that HLA-B*46:01 had the fewest predicted binding peptides for SARS-CoV-2, suggesting that individuals with this allele may be particularly vulnerable to COVID-19, as they were previously shown to be for SARS (M. |
T16 | 957-967 | Sentence | denotes | Lin, H.-T. |
T17 | 968-977 | Sentence | denotes | Tseng, J. |
T18 | 978-980 | Sentence | denotes | A. |
T19 | 981-995 | Sentence | denotes | Trejaut, H.-L. |
T20 | 996-1104 | Sentence | denotes | Lee, et al., BMC Med Genet 4:9, 2003, https://bmcmedgenet.biomedcentral.com/articles/10.1186/1471-2350-4-9). |
T21 | 1105-1341 | Sentence | denotes | Conversely, we found that HLA-B*15:03 showed the greatest capacity to present highly conserved SARS-CoV-2 peptides that are shared among common human coronaviruses, suggesting that it could enable cross-protective T-cell-based immunity. |
T22 | 1342-1481 | Sentence | denotes | Finally, we reported global distributions of HLA types with potential epidemiological ramifications in the setting of the current pandemic. |